NephroGenex raises $37.2 million in IPO

Kidney disease company NephroGenex Inc. (NASDAQ:NRX) raised $37.2 million in an IPO

Read the full 128 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE